UK Firm Offers Device As Corticosteroid Alternative, Seeks Marketing Partner
This article was originally published in The Gray Sheet
Executive Summary
Sinclair Pharmaceuticals, Ltd. anticipates a U.S. launch of its Atopiclair non-steroidal topical emulsion moisturizing cream within six to nine months of reaching a marketing agreement for the device